BactPac uses specialized bacteria engineered to safely deliver therapeutic payloads (mRNA, siRNA, proteins/nanobodies, and CRISPR/Cas) to targeted tissues. The company’s innovative platform can both produce and deliver nucleic acids safely and precisely to a wide range of tissues that cannot be targeted by viral vectors and lipid nanoparticles (LNPs).